Bruce Hart
General Counsel at Zymeworks BC, Inc.
Network origin in Bruce Hart first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
28
| Subsidiary | Biotechnology | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bruce Hart via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ZYMEWORKS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer President Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Investor Relations Contact Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO Chief Tech/Sci/R&D Officer Public Communications Contact | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| University of British Columbia | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Think Forwards | Corporate Officer/Principal Chief Executive Officer | ||
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
| Dream Foundation | Director/Board Member | ||
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Aventis, Inc. | Corporate Officer/Principal | ||
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer | |
| STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Chairman | |
UCB Biopharma SRL
 UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Medical Distributors | Corporate Officer/Principal | |
LetsGetChecked, Inc.
 LetsGetChecked, Inc. Medical SpecialtiesHealth Technology LetsGetChecked, Inc. operates online platform which connects customers and diagnostic laboratories. It offers its diagnostics services for general health, sexual health, cancer screening and fertility and hormone check. The company was founded by Peter Foley in 2014 and is headquartered in Dun Laoghaire, Ireland. | Medical Specialties | Director/Board Member | |
| SOPHIA GENETICS SA | Packaged Software | Chairman | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member | |
| University of Kentucky | College/University | Undergraduate Degree | |
MRM Proteomics, Inc.
 MRM Proteomics, Inc. BiotechnologyHealth Technology MRM Proteomics, Inc. provides proteomics services. Its products include PeptiQuant, protein quant and quality control kits. The firm offers PeptiQuant protein quantitation, protein characterization and tissue imaging services. The company was founded in 2010 and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| University of Glasgow School of Medicine | College/University | Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| 23ANDME HOLDING CO. | Biotechnology | Corporate Officer/Principal | |
| University of Alberta | College/University | Doctorate Degree | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder | |
| Alberta Bar Association | Corporate Officer/Principal | ||
| University of Missouri | College/University | Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 35 |
| Canada | 12 |
| Belgium | 3 |
| Switzerland | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 94 |
| Corporate Officer/Principal | 51 |
| Independent Dir/Board Member | 31 |
| Chief Tech/Sci/R&D Officer | 21 |
| Undergraduate Degree | 18 |
Most connected contacts
| Insiders | |
|---|---|
| Ken Galbraith | 30 |
| Susan Mahony | 21 |
| Troy Cox | 19 |
| Hollings Renton | 17 |
| Kelvin Neu | 15 |
| Diana Hausman | 13 |
| Ali Tehrani | 13 |
| Kenneth Hillan | 10 |
| Carlos Campoy | 10 |
| Christopher Astle | 10 |
| Neil Klompas | 9 |
| Jennifer Kaufman-Shaw | 8 |
| Nick Bedford | 8 |
| Paul Moore | 7 |
| Neil Josephson | 6 |
- Stock Market
- Insiders
- Bruce Hart
- Company connections
